Journal
BIOLOGICAL & PHARMACEUTICAL BULLETIN
Volume 25, Issue 9, Pages 1197-1202Publisher
PHARMACEUTICAL SOC JAPAN
DOI: 10.1248/bpb.25.1197
Keywords
Perilla frutescens; luteolin; anti-inflammation; anti-allergy; tumor necrosis factor-alpha
Categories
Ask authors/readers for more resources
Oral administration of the perilla leaf extract (PLE) to mice inhibits inflammation, allergic response, and tumor necrosis factor-a production. We also found that PLE suppressed the tumor necrosis factor-alpha (TNF-alpha) production in vitro. Using the inhibitory activity of TNF-a production in vitro as the index for isolation, we searched the active constituents from PLE and isolated luteolin, rosmarinic acid and caffeic acid as active components. Among the isolated compounds, only luteolin showed in vivo activity: inhibition of serum tumor necrosis factor-a production, inhibition of arachidonic acid-induced ear edema, inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced ear edema and inhibition of oxazolone-induced allergic edema. These results suggest that luteolin is a genuinely active constituent which is accountable for the oral effects of perilla.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available